Polymer Implant Delivers Drugs to Pancreatic Tumors
By HospiMedica International staff writers Posted on 28 Apr 2016 |
Image: The paclitaxel-delivering PLGA polymer film (Photo courtesy of Bryce Vickmark, MIT).
A novel implantable delivery platform can provide local chemotherapy for treating pancreatic ductal adenocarcinoma (PDAC), according to a new study.
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) and Massachusetts General Hospital (MGH; Boston, MA, USA), the implant is a biodegradable polymer flexible film made of poly lactic-co-glycolic acid (PLGA), and is designed to release high doses of chemotherapeutic drugs for up to 60 days. For delivery, the film is rolled into a tube and inserted through a catheter; once it reaches the pancreas, it unfolds and conforms to the shape of the tumor, releasing the embedded drugs only from the tumor-facing side to reduce side effects.
To compare the device's efficacy to that of traditional chemotherapy, a study was conducted in mice carrying human pancreatic tumors. One group of mice was treated with the implant carrying the chemo drug paclitaxel, while the other group received injections of the same drug for four weeks, simulating current treatment for human patients. The results showed that tumor growth slowed in mice with the implant; in some cases, the tumors even shrank. After four weeks, the implant group showed five times the paclitaxel concentration in their tumors that the intravenous group did.
In addition to successfully delivering the drug to the pancreas, the researchers also observed other positive effects. The localized treatment increased the amount of necrotic tissue, and since there are few blood vessels in pancreatic tumors, the paclitaxel tended to remain in-situ, preventing toxic effects in healthy tissues. Additionally, by acting as a physical barrier, the film was able to reduce metastasis to nearby organs. The study describing the implant and the murine study was published early online on March 31, 2016, in Biomaterials.
“The greatest benefit of this device is the ability to implant it with minimally invasive procedures, so we can give a tool to oncologists and surgeons to reach tumors that otherwise would be difficult to reach,” said lead author Laura Indolfi, PhD, of the MIT Institute for Medical Engineering and Science (IMES) and the MGH Cancer Center. “You can implant our device to achieve a localized drug release to control tumor progression and potentially shrink the tumor to a size where a surgeon can remove it.”
Pancreatic cancer patients often suffer from blockage of the bile duct, which interferes with digestion and is very painful. The duct can be reopened with a stent, but usually gets blocked again, requiring the patient to have the old stent removed and a new one inserted. According to the researchers, the film could also be used as a coating for such a stent, helping to prevent the cancer cells from spreading into the bile duct and blocking it again.
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Developed by researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) and Massachusetts General Hospital (MGH; Boston, MA, USA), the implant is a biodegradable polymer flexible film made of poly lactic-co-glycolic acid (PLGA), and is designed to release high doses of chemotherapeutic drugs for up to 60 days. For delivery, the film is rolled into a tube and inserted through a catheter; once it reaches the pancreas, it unfolds and conforms to the shape of the tumor, releasing the embedded drugs only from the tumor-facing side to reduce side effects.
To compare the device's efficacy to that of traditional chemotherapy, a study was conducted in mice carrying human pancreatic tumors. One group of mice was treated with the implant carrying the chemo drug paclitaxel, while the other group received injections of the same drug for four weeks, simulating current treatment for human patients. The results showed that tumor growth slowed in mice with the implant; in some cases, the tumors even shrank. After four weeks, the implant group showed five times the paclitaxel concentration in their tumors that the intravenous group did.
In addition to successfully delivering the drug to the pancreas, the researchers also observed other positive effects. The localized treatment increased the amount of necrotic tissue, and since there are few blood vessels in pancreatic tumors, the paclitaxel tended to remain in-situ, preventing toxic effects in healthy tissues. Additionally, by acting as a physical barrier, the film was able to reduce metastasis to nearby organs. The study describing the implant and the murine study was published early online on March 31, 2016, in Biomaterials.
“The greatest benefit of this device is the ability to implant it with minimally invasive procedures, so we can give a tool to oncologists and surgeons to reach tumors that otherwise would be difficult to reach,” said lead author Laura Indolfi, PhD, of the MIT Institute for Medical Engineering and Science (IMES) and the MGH Cancer Center. “You can implant our device to achieve a localized drug release to control tumor progression and potentially shrink the tumor to a size where a surgeon can remove it.”
Pancreatic cancer patients often suffer from blockage of the bile duct, which interferes with digestion and is very painful. The duct can be reopened with a stent, but usually gets blocked again, requiring the patient to have the old stent removed and a new one inserted. According to the researchers, the film could also be used as a coating for such a stent, helping to prevent the cancer cells from spreading into the bile duct and blocking it again.
Related Links:
Massachusetts Institute of Technology
Massachusetts General Hospital
Latest Surgical Techniques News
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots